Tislelizumab 300 mg solution for injection, Tevimbra 100 mg concentrate for solution for infusion
BGB-A317-316
Phase 3 small_molecule active
Quick answer
Tislelizumab 300 mg solution for injection, Tevimbra 100 mg concentrate for solution for infusion for Locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma is a Phase 3 program (small_molecule) at Beone Medicines Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Beone Medicines Ireland Limited
- Indication
- Locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active